Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAD
3476
DELISTED
Rite Aid Corporation
RAD
| $5.65M | ﹤0.01% |
838,166
+571,611
| +214% | +$3.78M |
|
3477
Sixth Street Specialty
TSLX
$1.78B
| $5.64M | ﹤0.01% |
305,131
+149,389
| +96% | +$3.16M |
|
|
FTCH
3478
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $5.64M | ﹤0.01% |
788,200
+190,300
| +32% | +$1.95M |
|
3479
Takeda Pharmaceutical
TAK
$56.3B
| $5.64M | ﹤0.01% |
401,766
+58,083
| +17% | +$829K |
|
3480
iShares MSCI China ETF
MCHI
$6.16B
| $5.63M | ﹤0.01% |
+100,794
| New | +$5.17M |
|
3481
Bolt Biotherapeutics
BOLT
$6.44M
| $5.62M | ﹤0.01% |
137,766
+158
| +0.1% | +$6.13K |
|
3482
CALL
Aramark
ARMK
$16.4B
| $5.62M | ﹤0.01% |
254,009
-13,989
| -5% | -$346K |
|
3483
CALL
Coty
COTY
$2.51B
| $5.6M | ﹤0.01% |
699,500
-355,900
| -34% | -$2.67M |
|
|
DVAX
3484
DELISTED
Dynavax Technologies
DVAX
| $5.6M | ﹤0.01% |
444,924
+72,589
| +19% | +$771K |
|
|
SWN
3485
CALL
DELISTED
Southwestern Energy Company
SWN
| $5.6M | ﹤0.01% |
896,300
+191,800
| +27% | +$1.48M |
|
3486
United States Natural Gas Fund
UNG
$487M
| $5.6M | ﹤0.01% |
+73,637
| New | +$7.59M |
|
|
NKLA
3487
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $5.6M | ﹤0.01% |
39,187
+12,970
| +49% | +$2.65M |
|
|
MON
3488
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
| $5.6M | ﹤0.01% |
569,784
-499,001
| -47% | -$4.9M |
|
|
ATAQ
3489
DELISTED
Altimar Acquisition Corp III
ATAQ
| $5.59M | ﹤0.01% |
570,238
-24,518
| -4% | -$240K |
|
3490
Annexon
ANNX
$1B
| $5.59M | ﹤0.01% |
1,483,663
-257,307
| -15% | -$786K |
|
3491
Avantis Core Fixed Income ETF
AVIG
$1.96B
| $5.59M | ﹤0.01% |
130,466
+107,465
| +467% | +$4.67M |
|
|
TWOU
3492
PUT
DELISTED
2U Inc
TWOU
| $5.59M | ﹤0.01% |
17,803
-2,954
| -14% | -$912K |
|
3493
CALL
Vanguard Total World Stock ETF
VT
$81.8B
| $5.59M | ﹤0.01% |
65,500
-47,900
| -42% | -$4.43M |
|
|
ITCI
3494
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.59M | ﹤0.01% |
97,900
+16,100
| +20% | +$913K |
|
|
SWI
3495
DELISTED
SolarWinds Corporation Common Stock
SWI
| $5.59M | ﹤0.01% |
544,932
+41,344
| +8% | +$490K |
|
3496
PUT
Lumentum
LITE
$82.1B
| $5.58M | ﹤0.01% |
70,300
-700
| -1% | -$59.8K |
|
3497
CALL
Deutsche Bank
DB
$72.5B
| $5.58M | ﹤0.01% |
638,500
-95,300
| -13% | -$1.02M |
|
3498
PUT
Lemonade
LMND
$4.07B
| $5.58M | ﹤0.01% |
305,600
-213,500
| -41% | -$4.5M |
|
3499
Cathay General Bancorp
CATY
$4.33B
| $5.58M | ﹤0.01% |
142,505
+114,292
| +405% | +$4.66M |
|
|
SGI
3500
CALL
Somnigroup International
SGI
$13.9B
| $5.58M | ﹤0.01% |
261,000
+158,500
| +155% | +$4.08M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.